UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Lilly beats Pfizer in treating early breast cancer
by Kim Yun-mi
2020-06-18 14:44
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
by Kim Yun-mi
2020-06-18 14:43
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
by Kim Yun-mi
2020-06-17 14:28
JW Pharma to recreate its anticancer therapy as Covid-19 drug
by Shim Hyun-tai
2020-06-17 14:26
Sanofi releases hemophilia A treatment
by Shim Hyun-tai
2020-06-16 17:27
라인
Sillajen CEO steps down
by Lee Han-soo
2020-06-16 16:49
MSD fails to present plausible reasons, grounds for discriminating against branches
by Lee Han-soo
2020-06-16 16:21
Gemvax & Kael's GV1001 shows efficacy as hepatitis B treatment
by Lee Han-soo
2020-06-16 16:18
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
by Kim Yun-mi
2020-06-16 11:44
Jardiance family of diabetes drugs sells ₩10 billion in Q1
by Kim Yun-mi
2020-06-15 17:39
라인
Biogen’s FDA application for Alzheimer’s drug drags on
by Kim Yun-mi
2020-06-15 12:09
Survey paints gloomy outlook for Korea’s developing Covid-19 treatment
by Shim Hyun-tai
2020-06-12 17:56
PharmAbcine inks CDMO deal with Australian firm for immunotherapy candidate
by Lee Han-soo
2020-06-12 17:15
Regulators OKs Pharmicell’s P2 trial of erectile dysfunction treatment
by Lee Han-soo
2020-06-12 16:07
Takeda’s sell-off of primary care biz to Celltrion triggers union protest
by Lee Han-soo
2020-06-12 15:32
라인
GC LabCell releases clinical results of NK cell therapy
by Shim Hyun-tai
2020-06-11 17:34
Genexine to start P1 trial of Covid-19 treatment in US
by Lee Han-soo
2020-06-11 16:26
MSD Korea’s trade union refuses to use controversial monitoring program
by Kim Yun-mi
2020-06-11 14:31
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
by Lee Han-soo
2020-06-10 17:58
‘Abbvie’s psoriasis drug proves long-term treatment effect’
by Shim Hyun-tai
2020-06-10 15:59
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top